课题基金 / 基金详情

Linking Disease Mechanisms and Outcomes in Rheumatic Diseases

Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
将风湿性疾病的疾病机制和结果联系起来
批准号:
10657643
负责人:
Joanne Michelle Kahlenberg
金额:
$13.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-06 至 2025-06-30
关键词:
ArthritisAutoimmuneAwardB-LymphocytesBiologyBiometryBiopsyCellsCenter for Translational Science ActivitiesChronicClinicalClinical TrialsClinical Trials DesignCollaborationsComplicationDataData SetDevelopmentDiseaseEnsureEnvironmentFatigueFibroblastsFibromyalgiaFosteringFunctional disorderFundingFutureGenotypeGoalsImmuneImmunophenotypingIn VitroInflammationInflammatoryInflammatory ResponseInfrastructureInstitutionInterferonsJointsLesionLinkLupusMapsMeasuresMentorsMentorshipMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchMissionMonitorMupirocinOutcomePainPain ResearchPathogenesisPatientsPharmaceutical PreparationsPhenotypePhysiciansPopulationPrediction of Response to TherapyProductionPsoriasisPsoriatic ArthritisPublic HealthRegulationResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingRheumatismRheumatologyScienceScientistSecureSensorySignal TransductionSkinStaphylococcus aureusSystemic Lupus ErythematosusT-LymphocyteTimeTopical applicationTraining ProgramsUltraviolet B RadiationUnited States National Institutes of HealthWorkautocrinebiomarker discoverycareerchemokinechronic painchronic widespread painclinical developmentcohortdisease phenotypeimprovedin vivoindexinginnovationkeratinocytelarge scale datalupus cutaneousmeetingsmicrobial colonizationmicrobial productsmonocytemouse modelnext generationnovelpain sensitivitypatient oriented researchpatient subsetspersonalized medicineprogramspromoterresearch facultyresponseskillsskin disordertooltraining opportunitytranslational research programtreatment response

项目摘要

项目成果

Joanne Michelle Kahlenberg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Mentorship has been identified as a critical facilitator for development of clinical research faculty. This K24 application seeks to provide protected time for the applicant to continue to mentor numerous trainees in patient- oriented research (POR) and to grow her current program in new directions to further expand opportunities to mentor in this arena. 30% of the applicant's effort will be protected by this award for these activities. The applicant has demonstrated significant abilities in mentoring trainees at all career stages and will continue to benefit from the rich and robust institutional environment that provides stellar research infrastructure and a large pool of patients and mentees to work with. During the funding period, further development of the applicant will include 1) Improvement in mentorship skills in POR; 2) Enhancement of biostatistics for POR; and 3) Construction of a collaborative niche for POR in pain in rheumatic disease. These skillsets will be achieved through a combination of seminars, meetings, courses, and collaboration with the U of M Chronic Pain and Fatigue Research Center and the U of M Fibromyalgia Center of Research Translation (CORT). In addition, these skillsets will integrate and grow through continued mentorship of trainees within currently funded POR and through expansion into pain research through the K24 mechanism. These research opportunities include: work that examines the biology of lupus skin in the context of patient presentation and disease phenotype (Project 1); A clinical trial examining the impact of microbial colonization on lupus skin inflammation (Project 2); A large, novel immunophenotyped cohort of lupus and psoriasis/psoriatic arthritis patients that provides large scale datasets for analysis and clinical correlation (Project 3) and; A new dataset collected to longitudinally map chronic pain and sensory sensitivity in patients with systemic lupus (Project 4). Successful completion of this award will result in successful mentoring of current and future mentees in POR and also enlarge the POR program of the applicant to ensure continued mentoring opportunities into the future.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/bor.0000000000000739
发表时间: 2020-11
期刊: Current opinion in rheumatology
影响因子: 5.1
作者: [Maz MP, Michelle Kahlenberg J]
通讯作者: Michelle Kahlenberg J
Mentorship of physician scientists: a critical imperative.
医师科学家的指导:至关重要。
DOI: 10.1038/s41590-021-00983-5
发表时间: 2021
期刊: Nature immunology
影响因子: 30.5
作者: [Kahlenberg,JMichelle]
通讯作者: Kahlenberg,JMichelle
DOI: 10.1097/bor.0000000000000770
发表时间: 2021-03-01
期刊: Current opinion in rheumatology
影响因子: 5.1
作者: [Hile GA, Kahlenberg JM]
通讯作者: Kahlenberg JM
DOI: 10.1172/jci.insight.171307
发表时间: 2023-08-22
期刊: JCI INSIGHT
影响因子: 8
作者: [Xing, Enze, Ma, Feiyang, Wasikowski, Rachael, Billi, Allison C., Gharaee-Kermani, Mehrnaz, Fox, Jennifer, Dobry, Craig, Victory, Amanda, Sarkar, Mrinal K., Xing, Xianying, Plazyo, Olesya, Chen, Henry W., Barber, Grant, Jacobe, Heidi, Tsou, Pei-Suen, Modlin, Robert L., Varga, John, Kahlenberg, J. Michelle, Tsoi, Lam C., Gudjonsson, Johann E., Khanna, Dinesh]
通讯作者: Khanna, Dinesh
7
    Hippo signaling as a critical regulator of lupus keratinocyte dysfunction
    • 批准号:
      10675692
    • 项目类别:
    • 资助金额:
      $49.61万
    • 财政年份:
      2022
    • 负责人:
      Joanne Michelle Kahlenberg
    • 依托单位:
    Hippo signaling as a critical regulator of lupus keratinocyte dysfunction
    • 批准号:
      10536347
    • 项目类别:
    • 资助金额:
      $46.68万
    • 财政年份:
      2022
    • 负责人:
      Joanne Michelle Kahlenberg
    • 依托单位:
    Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
    • 批准号:
      10210191
    • 项目类别:
    • 资助金额:
      $13.5万
    • 财政年份:
      2020
    • 负责人:
      Joanne Michelle Kahlenberg
    • 依托单位:
    Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
    • 批准号:
      10447037
    • 项目类别:
    • 资助金额:
      $13.5万
    • 财政年份:
      2020
    • 负责人:
      Joanne Michelle Kahlenberg
    • 依托单位:
    国内基金
    海外基金
    Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis